Latest DEF 14A proxy statements

Crawford United Corporation shareholders are set to vote on a definitive merger agreement with SPX Enterprises, LLC, valuing the company at an estimated $300 million, or $83.42 per share in cash.

Apartment Investment and Management Company (Aimco) has filed a definitive proxy statement for a special stockholder meeting to approve its Plan of Sale and Liquidation, aiming to maximize shareholder value.

Society Pass Incorporated's majority stockholders approved a new 2026 Equity Incentive Plan and the issuance of 2,272,727 common shares to recognize contributions to the NusaTrip IPO.

Synchronoss Technologies, Inc. announces its agreement to be acquired by Lumine Group, outlining 2025 achievements and 2026 strategic priorities.

Enviri Corporation announces CFO Tom Vadaketh's retirement, the appointment of Pete Minan as CFO for New Enviri, and confirms the Clean Earth sale and spin-off are on track for mid-2026.

Keen Vision Acquisition Corporation is seeking shareholder approval to extend its business combination deadline to July 27, 2026, to avoid liquidation.

Synchronoss Technologies, Inc. stockholders are invited to a special meeting on February 12, 2026, to vote on a proposed all-cash merger with Lumine Group US Holdco Inc. at $9.00 per share, representing a 70% premium.

Apartment Investment and Management Company (Aimco) seeks stockholder approval for a Plan of Sale and Liquidation, targeting total distributions of $8.58 to $9.93 per share, including prior special dividends.

ON24, Inc. announced a definitive agreement to be acquired by Cvent Atlanta, LLC for $8.10 per share in cash, with the transaction expected to close in the first half of 2026.

Bitmine Immersion Technologies, Inc. urges shareholders to vote FOR a proposal to increase authorized shares from 500 million to 50 billion to enable capital market activities, opportunistic deals, and future stock splits.

J&J Snack Foods Corp. has filed definitive additional proxy materials with the SEC.

J&J Snack Foods Corp. announces its 2026 Annual Meeting of Shareholders to address director election, auditor ratification, and executive compensation, following a challenging but strategically active fiscal year 2025.

Iterum Therapeutics plc calls an Extraordinary General Meeting to approve critical proposals for capital raising and Nasdaq compliance, warning of potential bankruptcy if not approved.

Medinotec, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on January 20, 2026, to elect five directors and approve its independent auditor.

Azitra, Inc. urges stockholders to approve a share issuance exceeding 19.99% to Alumni Capital LP, crucial for securing an additional $1.5 million in funding and avoiding severe operational risks.

Rallybio Corporation seeks stockholder approval for a reverse stock split to maintain its Nasdaq listing and enhance stock marketability.

SideChannel, Inc. announces its Annual Meeting of Stockholders to vote on director elections, a reverse stock split for potential uplisting, and auditor ratification, alongside reporting improved financial performance.

Moleculin Biotech, Inc. calls a Special Meeting to approve the issuance of up to 2.61 million shares from warrant exercises and a corporate name change to Moleculin Inc.

Bitmine Immersion Technologies proposes a massive increase in authorized shares to facilitate future capital activities and accommodate anticipated stock splits driven by Ethereum's projected price surge.

Cerence Inc. has filed its definitive proxy statement with the SEC, signaling an upcoming shareholder meeting.

Insteel Industries Inc. announces its 2026 Annual Meeting of Shareholders to be held on February 10, 2026, detailing proposals for director elections, executive compensation, and auditor ratification, alongside a review of strong fiscal 2025 financial performance.

Onconetix, Inc. is calling a special meeting of stockholders to vote on a reverse stock split proposal aimed at maintaining its Nasdaq listing and improving stock marketability.

Cerence Inc. details fiscal year 2025 achievements in generative AI and diversification, alongside leadership changes and strong executive compensation payouts, in its definitive proxy statement.

Profusa, Inc. calls a special meeting to vote on a reverse stock split, auditor ratification, and meeting adjournment, primarily to regain Nasdaq listing compliance.

Plug Power Inc. urges stockholders to vote on two crucial charter amendments to enhance financial flexibility and modernize governance ahead of a Special Meeting.

BioAtla, Inc. has adjourned its special stockholder meeting to January 12, 2026, to allow more time for voting on a proposed reverse stock split.

Galecto, Inc. is calling a special meeting to approve a redomestication to the Cayman Islands, increase authorized common stock, and establish new equity incentive plans following its Damora acquisition and $285 million financing.

Aemetis, Inc. is holding a Special Meeting on February 18, 2026, to vote on proposals to decrease authorized preferred stock and increase authorized common stock.

Tempest Therapeutics announces a strategic asset acquisition of CAR-T cell therapies from Erigen and Factor Bioscience, securing new funding and appointing a new CEO, subject to stockholder approval.

Axcelis Technologies and Veeco Instruments plan to combine in an all-stock merger of equals, creating a leading semiconductor equipment company.